Moreover, as demonstrated in Supplementary Figure S16D, STAT4 expression was characterized to had positive correlation with CTL infiltration levels in endometrial carcinoma (r = 0.584, p = 1.01e−50), acute myeloid leukemia (r = 0.418, p = 1.25e−4), neuroblastoma (r = 0.579, p = 3.52e−36), metastatic melanoma (r = 0.540, p = 2.37e−25), and triple negative breast cancer (r = 0.835, p = 8.30e−62). Here, STAT4 is linked to neuroblastoma.